Western blotting displayed that E2 could increase ERα expression levels in ZR‐75‐1 and MCF‐7 cells (Figure 3A), suggesting a significant positive correlation between ERα and CD44 in ER+ breast cancer cells. Here, CD44 is linked to breast carcinoma.